22157.jpg
Global $49.77 Cancer Monoclonal Antibodies Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
January 10, 2022 05:18 ET | Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Worldwide Immuno Oncology Assays Industry to 2026 - Clinical Trials to Cure Different Cancers in Immunotherapy Presents Opportunities
January 05, 2022 06:38 ET | Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Immuno Oncology Assays Market Research Report by Indication, Product, Technology, Application, and Region - Global Forecast to 2026 - Cumulative Impact...
22157.jpg
Worldwide T-Cell Therapy Industry to 2026 - Expanding Gene Therapy Marketspace Presents Opportunities
December 01, 2021 09:38 ET | Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "T-Cell Therapy Market Research Report by Modality, by Therapy Type, by Indication, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19"...
22157.jpg
Global Market for Immuno-Oncology Diagnostics 2021: Diagnostics Play New Key Role in Therapeutic Development and Clinical Trials
November 01, 2021 05:48 ET | Research and Markets
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates, 2022 - 2026" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global $92.97 Bn Immuno-Oncology Drugs Markets, 2015-2020, 2020-2025F, 2030F: Focus on Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines
September 29, 2021 06:18 ET | Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
Global $6.13 Billion CAR-T Cell Therapy Markets, 2017-2020 & 2021-2026: Focus on Yescarta, Kymriah, Tecartus, Breyanzi, Abecma, Others
September 28, 2021 04:28 ET | Research and Markets
Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Markets, Competition Forecast & Opportunities, 2021-2026" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global $15.1 Bn Immuno-oncology Clinical Trials Market to 2028
July 30, 2021 07:23 ET | Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Design...
LOGO.png
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
July 08, 2021 07:00 ET | Autolus Therapeutics plc
LONDON, July 08, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...
LOGO.png
Autolus Therapeutics Announces an Additional Nature Publication for AUTO1
May 25, 2021 07:00 ET | Autolus Therapeutics plc
LONDON, May 25, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a...
22157.jpg
Global Immuno-Oncology Assays Market (2021 to 2026) - Growing Significance of Companion Diagnostics Presents Opportunities
May 14, 2021 05:23 ET | Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications...